The Role of Magnesium in the Pathogenesis of Osteoporosis

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Jun 21

PMID 38904051

Authors

Lin Liu

Pan Luo

Pengfei Wen

Peng Xu

Affiliations

Soon will be listed here.

Abstract

Magnesium (Mg), a nutritional element which is essential for bone development and mineralization, has a role in the progression of osteoporosis. Osteoporosis is a multifactorial disease characterized by significant deterioration of bone microstructure and bone loss. Mg deficiency can affect bone structure in an indirect way through the two main regulators of calcium homeostasis (parathyroid hormone and vitamin D). In human osteoblasts (OBs), parathyroid hormone regulates the expression of receptor activator of nuclear factor-κ B ligand (RANKL) and osteoprotegerin (OPG) to affect osteoclast (OC) formation. In addition, Mg may also affect the vitamin D3 -mediated bone remodeling activity. vitamin D3 usually coordinates the activation of the OB and OC. The unbalanced activation OC leads to bone resorption. The RANK/RANKL/OPG axis is considered to be a key factor in the molecular mechanism of osteoporosis. Mg participates in the pathogenesis of osteoporosis by affecting the regulation of parathyroid hormone and vitamin D levels to affect the RANK/RANKL/OPG axis. Different factors affecting the axis and enhancing OC function led to bone loss and bone tissue microstructure damage, which leads to the occurrence of osteoporosis. Clinical research has shown that Mg supplementation can alleviate the symptoms of osteoporosis to some extent.

Citing Articles

Short-Term Magnesium Supplementation Has Modest Detrimental Effects on Cycle Ergometer Exercise Performance and Skeletal Muscle Mitochondria and Negligible Effects on the Gut Microbiota: A Randomized Crossover Clinical Trial.

Bomar M, Ewell T, Brown R, Brown D, Kwarteng B, Abbotts K Nutrients. 2025; 17(5).

PMID: 40077784 PMC: 11901567. DOI: 10.3390/nu17050915.

Osteoporosis: Causes, Mechanisms, Treatment and Prevention: Role of Dietary Compounds.

Stromsnes K, Martinez Fajardo C, Soto-Rodriguez S, Kajander E, Lupu R, Pozo-Rodriguez M Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770539 PMC: 11679375. DOI: 10.3390/ph17121697.

Towards Accurate Biocompatibility: Rethinking Cytotoxicity Evaluation for Biodegradable Magnesium Alloys in Biomedical Applications.

De Luca A, Ruggiero R, Cordaro A, Marrelli B, Raimondi L, Costa V J Funct Biomater. 2024; 15(12).

PMID: 39728182 PMC: 11678253. DOI: 10.3390/jfb15120382.

Magnesium Matters: A Comprehensive Review of Its Vital Role in Health and Diseases.

Fatima G, Dzupina A, B Alhmadi H, Magomedova A, Siddiqui Z, Mehdi A Cureus. 2024; 16(10):e71392.

PMID: 39539878 PMC: 11557730. DOI: 10.7759/cureus.71392.

References

Cui C, Driscoll R, Piao Y, Chia C, Gorospe M, Ferrucci L . Skewed macrophage polarization in aging skeletal muscle. Aging Cell. 2019; 18(6):e13032. PMC: 6826159. DOI: 10.1111/acel.13032. View

ISERI L, FRENCH J . Magnesium: nature's physiologic calcium blocker. Am Heart J. 1984; 108(1):188-93. DOI: 10.1016/0002-8703(84)90572-6. View

Jahnen-Dechent W, Ketteler M . Magnesium basics. Clin Kidney J. 2015; 5(Suppl 1):i3-i14. PMC: 4455825. DOI: 10.1093/ndtplus/sfr163. View

Gao Y, Patil S, Jia J . The Development of Molecular Biology of Osteoporosis. Int J Mol Sci. 2021; 22(15). PMC: 8347149. DOI: 10.3390/ijms22158182. View

ABRAHAM G, Grewal H . A total dietary program emphasizing magnesium instead of calcium. Effect on the mineral density of calcaneous bone in postmenopausal women on hormonal therapy. J Reprod Med. 1990; 35(5):503-7. View

Cheng C, Chen L, Chen K . Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover. Int J Mol Sci. 2022; 23(3). PMC: 8836058. DOI: 10.3390/ijms23031376. View

Gambardella J, De Rosa M, Sorriento D, Prevete N, Fiordelisi A, Ciccarelli M . Parathyroid Hormone Causes Endothelial Dysfunction by Inducing Mitochondrial ROS and Specific Oxidative Signal Transduction Modifications. Oxid Med Cell Longev. 2019; 2018:9582319. PMC: 6313989. DOI: 10.1155/2018/9582319. View

Kanzawa M, Sugimoto T, Kanatani M, Chihara K . Involvement of osteoprotegerin/osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells. Eur J Endocrinol. 2000; 142(6):661-4. DOI: 10.1530/eje.0.1420661. View

Shimizu E, Selvamurugan N, Westendorf J, Olson E, Partridge N . HDAC4 represses matrix metalloproteinase-13 transcription in osteoblastic cells, and parathyroid hormone controls this repression. J Biol Chem. 2010; 285(13):9616-9626. PMC: 2843211. DOI: 10.1074/jbc.M109.094862. View

10.

Neer R, Arnaud C, Zanchetta J, Prince R, Gaich G, Reginster J . Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001; 344(19):1434-41. DOI: 10.1056/NEJM200105103441904. View

11.

Street J, Bao M, deGuzman L, Bunting S, Peale Jr F, Ferrara N . Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A. 2002; 99(15):9656-61. PMC: 124965. DOI: 10.1073/pnas.152324099. View

12.

Feng W, Wang X, Huang D, Lu A . Role of diet in osteoporosis incidence: Umbrella review of meta-analyses of prospective observational studies. Crit Rev Food Sci Nutr. 2021; 63(19):3420-3429. DOI: 10.1080/10408398.2021.1989374. View

13.

Mayr-Wohlfart U, Waltenberger J, HAUSSER H, Kessler S, Gunther K, Dehio C . Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone. 2002; 30(3):472-7. DOI: 10.1016/s8756-3282(01)00690-1. View

14.

Capozzi A, Scambia G, Lello S . Calcium, vitamin D, vitamin K2, and magnesium supplementation and skeletal health. Maturitas. 2020; 140:55-63. DOI: 10.1016/j.maturitas.2020.05.020. View

15.

Yu J, Schilling L, Eller T, Canalis E . Hairy and enhancer of split 1 is a primary effector of NOTCH2 signaling and induces osteoclast differentiation and function. J Biol Chem. 2021; 297(6):101376. PMC: 8633688. DOI: 10.1016/j.jbc.2021.101376. View

16.

Huang J, Sakata T, Pfleger L, Bencsik M, Halloran B, Bikle D . PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res. 2004; 19(2):235-44. DOI: 10.1359/JBMR.0301226. View

17.

Fu R, Lv W, Xu Y, Gong M, Chen X, Jiang N . Endothelial ZEB1 promotes angiogenesis-dependent bone formation and reverses osteoporosis. Nat Commun. 2020; 11(1):460. PMC: 6978338. DOI: 10.1038/s41467-019-14076-3. View

18.

Guler E, Baripoglu Y, Alenezi H, Arikan A, Babazade R, Unal S . Vitamin D/vitamin K/magnesium-loaded polylactic acid/tricalcium phosphate/polycaprolactone composite nanofibers demonstrated osteoinductive effect by increasing Runx2 via Wnt/β-catenin pathway. Int J Biol Macromol. 2021; 190:244-258. DOI: 10.1016/j.ijbiomac.2021.08.196. View

19.

Pereira R, Salusky I, Bowen R, Freymiller E, Wesseling-Perry K . Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone. Bone. 2019; 127:626-634. PMC: 6715148. DOI: 10.1016/j.bone.2019.07.026. View

20.

Simental-Mendia L, Sahebkar A, Rodriguez-Moran M, Zambrano-Galvan G, Guerrero-Romero F . Effect of Magnesium Supplementation on Plasma C-reactive Protein Concentrations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Curr Pharm Des. 2017; 23(31):4678-4686. DOI: 10.2174/1381612823666170525153605. View